HMRC opened a new route to certainty on an R&D tax relief claim on 18 May 2026, running as a pilot until May 2027. Targeted advance assurance lets a small or medium-sized company ask HMRC, before it makes its claim, to look at up to two specific areas of that claim and say in writing whether its view holds. It sits alongside the older full claim advance assurance service for first-time claimants, and the two work differently enough that picking the wrong one wastes the application.
The four issues it covers
A targeted advance assurance application has to pick from a fixed list of four issues, and each application covers one project and one issue only, so a company asking about two issues on the same project files two applications. HMRC accepts a maximum of two applications per company for a period, which is where the "up to two areas" in the service's name comes from.
- Whether a specific project meets the definition of research and development for tax purposes.
- Whether expenditure on work carried out overseas qualifies for relief.
- Which party, where R&D is contracted from one company to another, is entitled to claim it.
- Whether the company qualifies for the exemption from the cap on the payable credit, which is otherwise £20,000 plus 300% of the company's PAYE and National Insurance for the period.
These are the four areas HMRC's own compliance checks spend the most time on, so getting a written answer before the claim is filed removes the largest sources of a later enquiry on that part of the claim.
Who can apply
The company must be an SME, must be carrying out R&D or planning to in the accounting period the application covers, must not have already claimed R&D tax relief for that period, and must not have already been given assurance on the same two areas for that period. A large company cannot apply, nor can a company seeking assurance on three or more areas, or one that has applied for full claim advance assurance for the same period. HMRC also refuses an application where the company or a connected person has entered a disclosable tax avoidance scheme, is a Corporate Serious Defaulter, or has an open enquiry into a Corporation Tax return.
This is a different test from full claim advance assurance, which is open only to a company making its first R&D claim, with turnover below £2 million and fewer than 50 employees, and which covers the whole of a claim rather than specific areas, for the first three accounting periods. A company cannot use both services for the same period or project, so a company already approaching its third or fourth claim, past the point full claim advance assurance would accept it, is exactly the kind of company targeted advance assurance was built for.
Worked example: a lab cost that sits outside the UK
- Nadia's company is developing a diagnostic test. Its accounting period runs to 31 December 2026, and it forecasts qualifying R&D expenditure of £340,000 for the year, including £95,000 paid to a contract laboratory in Switzerland for stability testing that needs a facility and a regulatory approval the UK does not have.
- The company is loss-making and its R&D spend is comfortably over 30% of total expenditure, so it expects to claim under Enhanced R&D Intensive Support, worth up to about 26.97p of cash per £1 of qualifying spend.
- If the £95,000 Swiss cost qualifies, the claim is worked out on £340,000: roughly £91,700. If it does not, because the exception for a genuinely unavailable UK facility is read narrowly, the claim drops to £245,000: roughly £66,100, a difference of about £25,600.
- Nadia also is not sure whether her company or the Swiss laboratory is the party entitled to claim the cost at all, since the contract was drafted before anyone thought about the tax position.
Nadia's company is an SME, has not yet claimed for the 2026 period, and has no enquiry, avoidance scheme or Corporate Serious Defaulter history to rule it out. It submits two targeted advance assurance applications before the year ends: one on whether the overseas expenditure qualifies, one on which party is entitled to claim the contracted-out cost. A written answer on both before the claim notification is due removes a £25,600 swing from the forecast she gives her board, and settles which company's accountant should even be preparing the figures.
How to apply
An application is made online, by the company or by an agent holding proper authorisation (form 64-8 or COMP1). The form cannot be saved part-way through and does not take attachments, so everything has to be gathered first: the company's registration number, the accounting period start date, the project's start date and a project overview, forecast R&D expenditure for the period, the type of records kept, the contact details of the competent professional and the senior officer putting their name to the application, and, where the issue is overseas expenditure, the reason the work could not be done in the UK. HMRC aims to process a complete, accurate application within 40 calendar days, and it cannot be appealed if HMRC decides not to give the assurance asked for.
The assurance that comes back covers only the issue and the period applied for, on the facts given in that application. It is not a substitute for the claim notification six months after the end of the period of account, or for the additional information form filed with the Company Tax Return; our post on the R&D claim notification deadline covers both. If the facts change materially after assurance is given, for example the overseas lab is swapped for a different one, the assurance no longer covers what is actually claimed.
What to do this week
- List every part of your current or next R&D claim where you are relying on a judgement call rather than a settled answer, and sort them against the four issues targeted advance assurance can cover.
- If overseas or contracted-out costs are the uncertain part, gather the contract and the reason any work happens outside the UK before you apply, since that is the evidence the application asks for.
- Check whether your company has already claimed for the period in question. An application made after the claim is filed is too late.
- If your company is on its first claim, turnover is under £2 million and fewer than 50 employees are on the payroll, compare full claim advance assurance against the targeted service before choosing either, since you cannot use both for the same period.
- Put the pilot's own end date, May 2027, against your own accounting period, since an area you plan to raise in a much later claim may fall outside the pilot altogether.
We prepare R&D claims for a fixed fee agreed before work starts, and that includes deciding whether a targeted advance assurance application is worth making before the claim itself is filed. See how we handle R&D claims, including for biotech companies whose R&D is mostly subcontracted. Your monthly accounting fee comes from the instant quote. Get started.









